Results 101 to 110 of about 2,161,254 (306)

COVID-19 and smoking in Russia: how are hospitalizations, course, and outcomes of coronavirus infection related to tobacco use?

Кардиоваскулярная терапия и профилактика
Aim. To study the relationship between the level of hospitalizations, se­vere course, and mortality from coronavirus disease 2019 (COVID-19) with the smoking prevalence in Russia for 2020-2021.Material and methods. The article analyzes data on the number
M. G. Gambaryan, M. G. Chashchin, A. V. Kontsevaya, A. Yu. Gorshkov, O. M. Drapkina   +4 more
doaj   +1 more source

Effects of health publicity on prevalence of smoking [PDF]

BMJ, 1994
EDITOR,—Joy Townsend and colleagues' study of the effects of price and health publicity on cigarette smoking used a broad definition of publicity, which may lead to misunderstandings.1 The definition was, in effect, a measure of “everything else except price”—which, as the authors acknowledge, comprises a much wider …
openaire   +2 more sources

Data Related to Meta-analysis of up to 622,409 individuals identifies 40 novel smoking behaviour associated genetic loci

, 2019
Here we have included four sets of meta-analysis results: Meta-analysis of discovery and replication cohorts, combining genotyped Exome-chip and Axiom array content for (i) Smoking Initiation, (ii) Cigarettes per day, and (iii) Smoking Cessation, and (iv)
CHD Exome+ consortium, GSCAN, Consortium for Genetics of Smoking Behaviour   +2 more
core   +1 more source

Association Between Smoking and Tuberculosis Infection: A Population Survey in a High Tuberculosis Incidence Area [PDF]

, 2005
Associations between smoking and tuberculosis disease including death from tuberculosis have been reported, but there are few reports on the influence of smoking on the risk of developing Mycobacterium tuberculosis infection. The aim of this study was to
Beyers, N., van Lill, S.W.P., Enarson, D.A., Borgdorff, M. W., Verver, S, Lombard, C.J, den Boon, S., Lombard, C. J., Beyers, N, Verver, S., Boon den, S, van Lill, S. W. P., Enarson, D. A., Bateman, E. D., Enarson, D.A, Bateman, E.D, Borgdorff, M.W., Borgdorff, M.W, Lombard, C.J., LIll van, P, Bateman, E.D.   +20 more
core   +2 more sources

Safety of Prescription Nonsteroidal Anti‐inflammatory Drugs in Adults With Inflammatory Bowel Disease: Data From a Large Administrative Claims Cohort

Arthritis Care &Research, EarlyView.
Objective The concern that nonsteroidal anti‐inflammatory drugs (NSAIDs) may precipitate flares of inflammatory bowel disease (IBD) has limited their use in managing musculoskeletal symptoms in those with IBD, but safety data are mixed. Methods This retrospective cohort study included patients with IBD aged at least 18 years from Optum's deidentified ...
Adam S. Mayer, Rui Xiao, Meenakshi Bewtra, Michael D. George, Pamela F. Weiss   +4 more
wiley   +1 more source

Prevalence of smoking and factors affecting smoking behaviour during pregnancy: A sample from Tekirdağ/Gebelikte sigara içme prevalansı ve sigara içme davranışını etkileyen etmenler: Tekirdağ örneği

Turkish Journal of Public Health, 2014
Objective: Smoking during pregnancy leads to serious health problems in the mother and the foetus. In our study, we determined the prevalence of smoking during pregnancy and associated factors in Tekirdağ.
Levent Cem Mutlu, Gamze Varol Saraçoğlu   +1 more
doaj  

Parental smoking and children's respiratory health: independent effects of prenatal and postnatal exposure. [PDF]

, 2006
OBJECTIVES: Adverse effects have been reported of prenatal and/or postnatal passive exposure to smoking on children's health. Uncertainties remain about the relative importance of smoking at different periods in the child's life. We investigate this in a
Hruba, F., Zlotkowska, Renata, Privalova, L., Janssen, Nicole, Splichalova, A., Heinrich, Joachim, Pattenden, S., Splichalova, Anna, Rudnai, Peter, Neuberger, M., De Sario, Manuela, Heinrich, J., Nikiforov, B., Luttmann-Gibson, Heike, Neuberger, Manfred, Antova, Temenuga, Luttmann-Gibson, H., Privalova, Larissa, Pattenden, Sam, Nikiforov, Bojidar, Fletcher, T., Grize, Leticia, Antova, T., Hruba, Frantiska, de Sario, M., Janssen, N., Fletcher, Tony, Rudnai, P., Grize, L., Zlotkowska, R.   +29 more
core   +1 more source

Artificial Intelligence in Systemic Sclerosis: Clinical Applications, Challenges, and Future Directions

Arthritis Care &Research, EarlyView.
Systemic sclerosis (SSc) is a rare autoimmune disease defined by immune dysregulation, vasculopathy, and progressive fibrosis of the skin and internal organs. Despite advances in care, major complications such as interstitial lung disease (ILD) and myocardial involvement remain the leading causes of morbidity and mortality.
Cristiana Sieiro Santos, José Miguel Sequí‐Sabater, Diego Benavent   +2 more
wiley   +1 more source

Discordance Between Patient and Physician Global Assessments in Early Systemic Sclerosis

Arthritis Care &Research, EarlyView.
Objective This study aims to identify factors associated with patient global assessment (PtGA) and physician global assessment (PhGA) and discordance between them in systemic sclerosis (SSc). Methods Data from adults with early SSc (<5 years) from the Collaborative National Quality and Efficacy Registry were included.
Ellen Romich, Alexis Ogdie, Alisa Stephens Shields, Peter A. Merkel, Shervin Assassi, Elana J. Bernstein, Andreea Bujor, Flavia V. Castelino, Lorinda Chung, Luke B. Evnin, Tracy M. Frech, Jessica K. Gordon, Melissa Griffith, Faye N. Hant, Monica L. Harding, Laura K. Hummers, Dinesh Khanna, Kimberly S. Lakin, Dorota J. Lebiedz‐Odrobina, Yiming Luo, Ashima Makol, Maureen D. Mayes, Zsuzsanna H. McMahan, Jerry Molitor, Duncan F. Moore, Julie Paik, Carrie Richardson, Brian Skaug, Ami A. Shah, Ankoor Shah, Virginia Steen, John M. VanBuren, Elizabeth R. Volkmann, Carleigh Zahn, Nora Sandorfi, for the CONQUER Investigators   +35 more
wiley   +1 more source

Projecting future smoking prevalence to 2025 and beyond in New Zealand using smoking prevalence data from the 2013 census

, 2014
Background We have previously published a forecasting model of future smoking prevalence in New Zealand (NZ). Under business-as-usual (BAU) assumptions NZ’s smokefree 2025 goal was not attained by any demographic group.
Ikeda, T, van der Deen, FS, Wilson, N, Cobiac, L, Blakely, T   +4 more
core